248 related articles for article (PubMed ID: 35969834)
41. Severity of Acute Graft-versus-Host Disease and Associated Healthcare Resource Utilization, Cost, and Outcomes.
Farhadfar N; Leather HL; Wang S; Burton N; IrizarryGatell V; Itzler R; Salloum RG; Wingard JR
Transplant Cell Ther; 2021 Dec; 27(12):1007.e1-1007.e8. PubMed ID: 34537422
[TBL] [Abstract][Full Text] [Related]
42. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients.
Ilett EE; Jørgensen M; Noguera-Julian M; Nørgaard JC; Daugaard G; Helleberg M; Paredes R; Murray DD; Lundgren J; MacPherson C; Reekie J; Sengeløv H
Blood Adv; 2020 Nov; 4(22):5797-5809. PubMed ID: 33232475
[TBL] [Abstract][Full Text] [Related]
43. The association between acute graft-versus-host disease and antimicrobial peptide expression in the gastrointestinal tract after allogeneic stem cell transplantation.
Weber D; Frauenschläger K; Ghimire S; Peter K; Panzer I; Hiergeist A; Weber M; Kutny D; Wolff D; Grube M; Huber E; Oefner P; Gessner A; Hehlgans T; Herr W; Holler E
PLoS One; 2017; 12(9):e0185265. PubMed ID: 28934349
[TBL] [Abstract][Full Text] [Related]
44. An investigation of the potential association between gastrointestinal viral and bacterial infection and development of intestinal acute graft versus host disease following allogeneic hematopoietic stem cell transplantation.
Bueno F; Albert E; Giménez E; Piñana JL; Pérez A; Dolores Gómez M; Hernández-Boluda JC; Gonzalez-Barberá EM; Montoro J; Buesa J; Guerreiro M; Balaguer-Roselló A; Hernani R; Sanz J; Solano C; Navarro D
J Med Virol; 2021 Aug; 93(8):4773-4779. PubMed ID: 33605457
[TBL] [Abstract][Full Text] [Related]
45. The distribution of intestinal flora after hematopoietic stem cell transplantation in children.
Tong L; Meng Y; Zhang L; Yu J; Dou Y
Pediatr Transplant; 2024 Feb; 28(1):e14678. PubMed ID: 38148707
[TBL] [Abstract][Full Text] [Related]
46. Profiling the Fungal Microbiome after Fecal Microbiota Transplantation for Graft-versus-Host Disease: Insights from a Phase 1 Interventional Study.
van Lier YF; Rolling T; Armijo GK; Zhai B; Haverkate NJE; Meijer E; Nur E; Blom B; Peled JU; van den Brink MRM; Hohl TM; Hazenberg MD; Markey KA
Transplant Cell Ther; 2023 Jan; 29(1):63.e1-63.e5. PubMed ID: 36280104
[TBL] [Abstract][Full Text] [Related]
47. Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
Ingham AC; Kielsen K; Mordhorst H; Ifversen M; Aarestrup FM; Müller KG; Pamp SJ
Microbiome; 2021 Jun; 9(1):148. PubMed ID: 34183060
[TBL] [Abstract][Full Text] [Related]
48. Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation.
Fujiwara H
Front Immunol; 2021; 12():703298. PubMed ID: 34512627
[TBL] [Abstract][Full Text] [Related]
49. Impact of decontamination therapy on gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic cell transplantation in children: Decontamination therapy in allo-HCT.
Gałązka P; Styczyński J; Czyżewski K; Salamonowicz-Bodzioch M; Frączkiewicz J; Zając-Spychała O; Zaucha-Prażmo A; Goździk J; Biliński J; Basak GW
Curr Res Transl Med; 2021 Jul; 69(3):103298. PubMed ID: 34144374
[TBL] [Abstract][Full Text] [Related]
50. Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders.
Biagi E; Zama D; Rampelli S; Turroni S; Brigidi P; Consolandi C; Severgnini M; Picotti E; Gasperini P; Merli P; Decembrino N; Zecca M; Cesaro S; Faraci M; Prete A; Locatelli F; Pession A; Candela M; Masetti R
BMC Med Genomics; 2019 Mar; 12(1):49. PubMed ID: 30845942
[TBL] [Abstract][Full Text] [Related]
51. Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature.
Biernat MM; Urbaniak-Kujda D; Dybko J; Kapelko-Słowik K; Prajs I; Wróbel T
J Int Med Res; 2020 Jun; 48(6):300060520925693. PubMed ID: 32527171
[TBL] [Abstract][Full Text] [Related]
52. Microbiome Anomalies in Allogeneic Hematopoietic Cell Transplantation.
Schwabkey ZI; Jenq RR
Annu Rev Med; 2020 Jan; 71():137-148. PubMed ID: 31986084
[TBL] [Abstract][Full Text] [Related]
53. The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.
Gao MG; Hong Y; Zhao XY; Pan XA; Sun YQ; Kong J; Wang ZD; Wang FR; Wang JZ; Yan CH; Wang Y; Huang XJ; Zhao XS
Front Immunol; 2021; 12():720354. PubMed ID: 34539656
[TBL] [Abstract][Full Text] [Related]
54. Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation.
Yu J; Parasuraman S; Shah A; Weisdorf D
Curr Med Res Opin; 2019 Jun; 35(6):983-988. PubMed ID: 30461314
[TBL] [Abstract][Full Text] [Related]
55. [Fecal metabolomic profiles in experimental murine bone marrow transplantation].
Sekiguchi E; Toubai T; Suto M; Matsuki E; Miyata M; Ishizawa K
Rinsho Ketsueki; 2022; 63(1):37-44. PubMed ID: 35135950
[TBL] [Abstract][Full Text] [Related]
56. Viral PCR positivity in stool before allogeneic hematopoietic cell transplantation is strongly associated with acute intestinal graft-versus-host disease.
van Montfrans J; Schulz L; Versluys B; de Wildt A; Wolfs T; Bierings M; Gerhardt C; Lindemans C; Wensing A; Boelens JJ
Biol Blood Marrow Transplant; 2015 Apr; 21(4):772-4. PubMed ID: 25598276
[TBL] [Abstract][Full Text] [Related]
57. Effect of GVHD on the gut and intestinal microflora.
Ji H; Feng S; Liu Y; Cao Y; Lou H; Li Z
Transpl Immunol; 2024 Feb; 82():101977. PubMed ID: 38184214
[TBL] [Abstract][Full Text] [Related]
58. Association between histopathological alterations and diarrhea severity in acute intestinal graft-versus-host disease.
da Costa LNG; Costa-Lima C; de Meirelles LR; Carvalho RB; Colella MP; Aranha FJP; Vigorito AC; De Paula EV
Medicine (Baltimore); 2018 May; 97(19):e0600. PubMed ID: 29742694
[TBL] [Abstract][Full Text] [Related]
59. Fecal Microbiota Transplantation: Restoring the Injured Microbiome after Allogeneic Hematopoietic Cell Transplantation.
DeFilipp Z; Hohmann E; Jenq RR; Chen YB
Biol Blood Marrow Transplant; 2019 Jan; 25(1):e17-e22. PubMed ID: 30408565
[TBL] [Abstract][Full Text] [Related]
60. The contribution of the intestinal microbiome to immune recovery after HCT.
Wolfe AE; Markey KA
Front Immunol; 2022; 13():988121. PubMed ID: 36059482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
